SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-053878
Filing Date
2015-07-28
Accepted
2015-07-28 17:00:39
Documents
1
Period of Report
2015-07-24

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3852
  Complete submission text file 0001104659-15-053878.txt   5451
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNERGY PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 2012 NEW YORK NY 10170
Business Address
Griffin Patrick (Reporting) CIK: 0001633942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 151010302